MDR1/P Glycoprotein Expression in Human Sarcomas
Author Information
Author(s): B. Vergier, L. Cany, F. Bonnet, J. Robert, A. de Mascarel, J.M. Coindre
Primary Institution: Fondation Bergonie
Hypothesis
What is the expression of MDR1 gene in clinically drug-resistant sarcomas?
Conclusion
MDR1 overexpression occurs in human sarcomas, but it is not the main mechanism of drug resistance.
Supporting Evidence
- Only one of the 22 sarcomas showed increased MDR1 mRNA expression.
- Immunohistochemistry revealed positive staining in tumoral cells of 12 other sarcomas.
- Positivity with one antibody does not imply the presence of P-glycoprotein.
Takeaway
This study looked at how a gene related to drug resistance is expressed in certain tumors, finding that it is present in some but not the main reason why the tumors resist treatment.
Methodology
The study analyzed MDR1 expression at the mRNA level using Northern blot, Dot blot, and in situ hybridization, and at the protein level using immunohistochemistry with three monoclonal antibodies.
Limitations
The study's findings may not be generalizable due to the small sample size and the specific focus on clinically drug-resistant sarcomas.
Participant Demographics
Patients with sarcoma diagnosed and treated at the Fondation Bergonie, all presenting clinical drug resistance.
Want to read the original?
Access the complete publication on the publisher's website